BHCM
ALAB icon

Brevan Howard Capital Management’s Astera Labs ALAB Stock Holding History

Brevan Howard Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16M Buy
+33,091
New +$8.78M 0.12% 124
2025
Q4 		– Sell
-186,984
Closed -$36.6M – 2342
2025
Q3 		$36.6M Buy
186,984
+112,518
+151% +$18.5M 0.16% 49
2025
Q2 		$6.73M Buy
+74,466
New +$5.88M 0.04% 266
2024
Q2 		– Sell
-5,025
Closed -$373K – 1447
2024
Q1 		$373K Buy
+5,025
New +$372K ﹤0.01% 569

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brevan Howard Capital Management's ALAB Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Astera Labs (ALAB) in Q2 2026: 33,091 shares worth $16M. The stake represents 0.12% of the portfolio and ranks #124 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in ALAB as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in ALAB in Q1 2024 and has held it in 4 quarters since. The position peaked at $36.6M in Q3 2025. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Brevan Howard Capital Management held 33,091 shares of Astera Labs worth $16M as of Q2 2026.
  • Astera Labs was a new Brevan Howard Capital Management position in Q2 2026.
  • Astera Labs made up 0.12% of Brevan Howard Capital Management's portfolio in Q2 2026, its #124 holding.
  • Brevan Howard Capital Management first reported a position in Astera Labs in Q1 2024 and has held it in 4 quarters since.
  • Brevan Howard Capital Management's Astera Labs position peaked at $36.6M in Q3 2025.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.